Tao et al. developed a magnolol-sulforaphane hybrid, CT1-3, which showed pro-apoptotic effects in cancer cells by increasing ROS generation and Bax expression while decreasing ΔΨm and Bcl-2 levels [116]. This evidence concerns the gene BCL2 and cancer.